Literature DB >> 23691553

Response to letter regarding article, “histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid”.

Lan Zhao, Chien-Nien Chen, Nabil Hajji, Eduardo Oliver, Emanuele Cotroneo, John Wharton, Martin R Wilkins, Daren Wang, Min Li, Kurt R Stenmark, Timothy A McKinsey, Peter Buttrick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23691553     DOI: 10.1161/circulationaha.112.154757

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  2 in total

Review 1.  Emerging roles for histone deacetylases in pulmonary hypertension and right ventricular remodeling (2013 Grover Conference series).

Authors:  Maria A Cavasin; Kurt R Stenmark; Timothy A McKinsey
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

2.  Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension disease.

Authors:  Malik Bisserier; Radoslav Janostiak; Frank Lezoualc'h; Lahouaria Hadri
Journal:  Vasc Biol       Date:  2020-01-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.